Report Overview
Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a "catch-all" for all non-LVP parenterals products except biologicals.
The global Parenteral Drugs market size was estimated at USD 15310 million in 2023 and is projected to reach USD 21980.21 million by 2032, exhibiting a CAGR of 4.10% during the forecast period.
North America Parenteral Drugs market size was estimated at USD 4274.67 million in 2023, at a CAGR of 3.51% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Parenteral Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parenteral Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parenteral Drugs market in any manner.
Global Parenteral Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
Market Segmentation (by Type)
LVP Drug
SVP Drug
Market Segmentation (by Application)
Hospitals
Medical Centers
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Parenteral Drugs Market
Overview of the regional outlook of the Parenteral Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Parenteral Drugs
1.2 Key Market Segments
1.2.1 Parenteral Drugs Segment by Type
1.2.2 Parenteral Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Parenteral Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Parenteral Drugs Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Parenteral Drugs Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Parenteral Drugs Market Competitive Landscape
3.1 Global Parenteral Drugs Sales by Manufacturers (2019-2024)
3.2 Global Parenteral Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parenteral Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parenteral Drugs Sales Sites, Area Served, Product Type
3.6 Parenteral Drugs Market Competitive Situation and Trends
3.6.1 Parenteral Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parenteral Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Parenteral Drugs Industry Chain Analysis
4.1 Parenteral Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Parenteral Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Parenteral Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parenteral Drugs Sales Market Share by Type (2019-2024)
6.3 Global Parenteral Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Parenteral Drugs Price by Type (2019-2024)
7 Parenteral Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parenteral Drugs Market Sales by Application (2019-2024)
7.3 Global Parenteral Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Parenteral Drugs Sales Growth Rate by Application (2019-2024)
8 Parenteral Drugs Market Consumption by Region
8.1 Global Parenteral Drugs Sales by Region
8.1.1 Global Parenteral Drugs Sales by Region
8.1.2 Global Parenteral Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Parenteral Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parenteral Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parenteral Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parenteral Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parenteral Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Parenteral Drugs Market Production by Region
9.1 Global Production of Parenteral Drugs by Region (2019-2024)
9.2 Global Parenteral Drugs Revenue Market Share by Region (2019-2024)
9.3 Global Parenteral Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Parenteral Drugs Production
9.4.1 North America Parenteral Drugs Production Growth Rate (2019-2024)
9.4.2 North America Parenteral Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Parenteral Drugs Production
9.5.1 Europe Parenteral Drugs Production Growth Rate (2019-2024)
9.5.2 Europe Parenteral Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Parenteral Drugs Production (2019-2024)
9.6.1 Japan Parenteral Drugs Production Growth Rate (2019-2024)
9.6.2 Japan Parenteral Drugs Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Parenteral Drugs Production (2019-2024)
9.7.1 China Parenteral Drugs Production Growth Rate (2019-2024)
9.7.2 China Parenteral Drugs Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Ostuka Pharmaceutical
10.1.1 Ostuka Pharmaceutical Parenteral Drugs Basic Information
10.1.2 Ostuka Pharmaceutical Parenteral Drugs Product Overview
10.1.3 Ostuka Pharmaceutical Parenteral Drugs Product Market Performance
10.1.4 Ostuka Pharmaceutical Business Overview
10.1.5 Ostuka Pharmaceutical Parenteral Drugs SWOT Analysis
10.1.6 Ostuka Pharmaceutical Recent Developments
10.2 Teva Pharmaceutical Industries
10.2.1 Teva Pharmaceutical Industries Parenteral Drugs Basic Information
10.2.2 Teva Pharmaceutical Industries Parenteral Drugs Product Overview
10.2.3 Teva Pharmaceutical Industries Parenteral Drugs Product Market Performance
10.2.4 Teva Pharmaceutical Industries Business Overview
10.2.5 Teva Pharmaceutical Industries Parenteral Drugs SWOT Analysis
10.2.6 Teva Pharmaceutical Industries Recent Developments
10.3 Kelun Pharma
10.3.1 Kelun Pharma Parenteral Drugs Basic Information
10.3.2 Kelun Pharma Parenteral Drugs Product Overview
10.3.3 Kelun Pharma Parenteral Drugs Product Market Performance
10.3.4 Kelun Pharma Parenteral Drugs SWOT Analysis
10.3.5 Kelun Pharma Business Overview
10.3.6 Kelun Pharma Recent Developments
10.4 Cook Pharmica
10.4.1 Cook Pharmica Parenteral Drugs Basic Information
10.4.2 Cook Pharmica Parenteral Drugs Product Overview
10.4.3 Cook Pharmica Parenteral Drugs Product Market Performance
10.4.4 Cook Pharmica Business Overview
10.4.5 Cook Pharmica Recent Developments
10.5 Patheon
10.5.1 Patheon Parenteral Drugs Basic Information
10.5.2 Patheon Parenteral Drugs Product Overview
10.5.3 Patheon Parenteral Drugs Product Market Performance
10.5.4 Patheon Business Overview
10.5.5 Patheon Recent Developments
10.6 BAG Healthcare
10.6.1 BAG Healthcare Parenteral Drugs Basic Information
10.6.2 BAG Healthcare Parenteral Drugs Product Overview
10.6.3 BAG Healthcare Parenteral Drugs Product Market Performance
10.6.4 BAG Healthcare Business Overview
10.6.5 BAG Healthcare Recent Developments
10.7 Beximco Pharma
10.7.1 Beximco Pharma Parenteral Drugs Basic Information
10.7.2 Beximco Pharma Parenteral Drugs Product Overview
10.7.3 Beximco Pharma Parenteral Drugs Product Market Performance
10.7.4 Beximco Pharma Business Overview
10.7.5 Beximco Pharma Recent Developments
10.8 Baxter Healthcare Corporation
10.8.1 Baxter Healthcare Corporation Parenteral Drugs Basic Information
10.8.2 Baxter Healthcare Corporation Parenteral Drugs Product Overview
10.8.3 Baxter Healthcare Corporation Parenteral Drugs Product Market Performance
10.8.4 Baxter Healthcare Corporation Business Overview
10.8.5 Baxter Healthcare Corporation Recent Developments
10.9 B. Braun
10.9.1 B. Braun Parenteral Drugs Basic Information
10.9.2 B. Braun Parenteral Drugs Product Overview
10.9.3 B. Braun Parenteral Drugs Product Market Performance
10.9.4 B. Braun Business Overview
10.9.5 B. Braun Recent Developments
10.10 Fresenius
10.10.1 Fresenius Parenteral Drugs Basic Information
10.10.2 Fresenius Parenteral Drugs Product Overview
10.10.3 Fresenius Parenteral Drugs Product Market Performance
10.10.4 Fresenius Business Overview
10.10.5 Fresenius Recent Developments
10.11 Albert David
10.11.1 Albert David Parenteral Drugs Basic Information
10.11.2 Albert David Parenteral Drugs Product Overview
10.11.3 Albert David Parenteral Drugs Product Market Performance
10.11.4 Albert David Business Overview
10.11.5 Albert David Recent Developments
10.12 BML Parenteral Drugs
10.12.1 BML Parenteral Drugs Parenteral Drugs Basic Information
10.12.2 BML Parenteral Drugs Parenteral Drugs Product Overview
10.12.3 BML Parenteral Drugs Parenteral Drugs Product Market Performance
10.12.4 BML Parenteral Drugs Business Overview
10.12.5 BML Parenteral Drugs Recent Developments
10.13 Pfizer (Hospira)
10.13.1 Pfizer (Hospira) Parenteral Drugs Basic Information
10.13.2 Pfizer (Hospira) Parenteral Drugs Product Overview
10.13.3 Pfizer (Hospira) Parenteral Drugs Product Market Performance
10.13.4 Pfizer (Hospira) Business Overview
10.13.5 Pfizer (Hospira) Recent Developments
10.14 Pisa
10.14.1 Pisa Parenteral Drugs Basic Information
10.14.2 Pisa Parenteral Drugs Product Overview
10.14.3 Pisa Parenteral Drugs Product Market Performance
10.14.4 Pisa Business Overview
10.14.5 Pisa Recent Developments
10.15 Ozon Pharmaceuticals Ltd
10.15.1 Ozon Pharmaceuticals Ltd Parenteral Drugs Basic Information
10.15.2 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Overview
10.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Market Performance
10.15.4 Ozon Pharmaceuticals Ltd Business Overview
10.15.5 Ozon Pharmaceuticals Ltd Recent Developments
10.16 Aspen Holdings
10.16.1 Aspen Holdings Parenteral Drugs Basic Information
10.16.2 Aspen Holdings Parenteral Drugs Product Overview
10.16.3 Aspen Holdings Parenteral Drugs Product Market Performance
10.16.4 Aspen Holdings Business Overview
10.16.5 Aspen Holdings Recent Developments
10.17 PSI Ltd
10.17.1 PSI Ltd Parenteral Drugs Basic Information
10.17.2 PSI Ltd Parenteral Drugs Product Overview
10.17.3 PSI Ltd Parenteral Drugs Product Market Performance
10.17.4 PSI Ltd Business Overview
10.17.5 PSI Ltd Recent Developments
10.18 Wintac Limited
10.18.1 Wintac Limited Parenteral Drugs Basic Information
10.18.2 Wintac Limited Parenteral Drugs Product Overview
10.18.3 Wintac Limited Parenteral Drugs Product Market Performance
10.18.4 Wintac Limited Business Overview
10.18.5 Wintac Limited Recent Developments
10.19 AXA Parenterals Ltd
10.19.1 AXA Parenterals Ltd Parenteral Drugs Basic Information
10.19.2 AXA Parenterals Ltd Parenteral Drugs Product Overview
10.19.3 AXA Parenterals Ltd Parenteral Drugs Product Market Performance
10.19.4 AXA Parenterals Ltd Business Overview
10.19.5 AXA Parenterals Ltd Recent Developments
10.20 Acebright
10.20.1 Acebright Parenteral Drugs Basic Information
10.20.2 Acebright Parenteral Drugs Product Overview
10.20.3 Acebright Parenteral Drugs Product Market Performance
10.20.4 Acebright Business Overview
10.20.5 Acebright Recent Developments
10.21 Southwest Pharmaceutical
10.21.1 Southwest Pharmaceutical Parenteral Drugs Basic Information
10.21.2 Southwest Pharmaceutical Parenteral Drugs Product Overview
10.21.3 Southwest Pharmaceutical Parenteral Drugs Product Market Performance
10.21.4 Southwest Pharmaceutical Business Overview
10.21.5 Southwest Pharmaceutical Recent Developments
10.22 Abbott
10.22.1 Abbott Parenteral Drugs Basic Information
10.22.2 Abbott Parenteral Drugs Product Overview
10.22.3 Abbott Parenteral Drugs Product Market Performance
10.22.4 Abbott Business Overview
10.22.5 Abbott Recent Developments
11 Parenteral Drugs Market Forecast by Region
11.1 Global Parenteral Drugs Market Size Forecast
11.2 Global Parenteral Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Parenteral Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Parenteral Drugs Market Size Forecast by Region
11.2.4 South America Parenteral Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Parenteral Drugs by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Parenteral Drugs Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Parenteral Drugs by Type (2025-2032)
12.1.2 Global Parenteral Drugs Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Parenteral Drugs by Type (2025-2032)
12.2 Global Parenteral Drugs Market Forecast by Application (2025-2032)
12.2.1 Global Parenteral Drugs Sales (K MT) Forecast by Application
12.2.2 Global Parenteral Drugs Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Parenteral Drugs Market Size Comparison by Region (M USD)
Table 5. Global Parenteral Drugs Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Parenteral Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Parenteral Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Parenteral Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Drugs as of 2022)
Table 10. Global Market Parenteral Drugs Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Parenteral Drugs Sales Sites and Area Served
Table 12. Manufacturers Parenteral Drugs Product Type
Table 13. Global Parenteral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Parenteral Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Parenteral Drugs Market Challenges
Table 22. Global Parenteral Drugs Sales by Type (K MT)
Table 23. Global Parenteral Drugs Market Size by Type (M USD)
Table 24. Global Parenteral Drugs Sales (K MT) by Type (2019-2024)
Table 25. Global Parenteral Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Parenteral Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Parenteral Drugs Market Size Share by Type (2019-2024)
Table 28. Global Parenteral Drugs Price (USD/MT) by Type (2019-2024)
Table 29. Global Parenteral Drugs Sales (K MT) by Application
Table 30. Global Parenteral Drugs Market Size by Application
Table 31. Global Parenteral Drugs Sales by Application (2019-2024) & (K MT)
Table 32. Global Parenteral Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Parenteral Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Parenteral Drugs Market Share by Application (2019-2024)
Table 35. Global Parenteral Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Parenteral Drugs Sales by Region (2019-2024) & (K MT)
Table 37. Global Parenteral Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Parenteral Drugs Sales by Country (2019-2024) & (K MT)
Table 39. Europe Parenteral Drugs Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Parenteral Drugs Sales by Region (2019-2024) & (K MT)
Table 41. South America Parenteral Drugs Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Parenteral Drugs Sales by Region (2019-2024) & (K MT)
Table 43. Global Parenteral Drugs Production (K MT) by Region (2019-2024)
Table 44. Global Parenteral Drugs Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Parenteral Drugs Revenue Market Share by Region (2019-2024)
Table 46. Global Parenteral Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Parenteral Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Parenteral Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Parenteral Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Parenteral Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Ostuka Pharmaceutical Parenteral Drugs Basic Information
Table 52. Ostuka Pharmaceutical Parenteral Drugs Product Overview
Table 53. Ostuka Pharmaceutical Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Ostuka Pharmaceutical Business Overview
Table 55. Ostuka Pharmaceutical Parenteral Drugs SWOT Analysis
Table 56. Ostuka Pharmaceutical Recent Developments
Table 57. Teva Pharmaceutical Industries Parenteral Drugs Basic Information
Table 58. Teva Pharmaceutical Industries Parenteral Drugs Product Overview
Table 59. Teva Pharmaceutical Industries Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Teva Pharmaceutical Industries Business Overview
Table 61. Teva Pharmaceutical Industries Parenteral Drugs SWOT Analysis
Table 62. Teva Pharmaceutical Industries Recent Developments
Table 63. Kelun Pharma Parenteral Drugs Basic Information
Table 64. Kelun Pharma Parenteral Drugs Product Overview
Table 65. Kelun Pharma Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Kelun Pharma Parenteral Drugs SWOT Analysis
Table 67. Kelun Pharma Business Overview
Table 68. Kelun Pharma Recent Developments
Table 69. Cook Pharmica Parenteral Drugs Basic Information
Table 70. Cook Pharmica Parenteral Drugs Product Overview
Table 71. Cook Pharmica Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Cook Pharmica Business Overview
Table 73. Cook Pharmica Recent Developments
Table 74. Patheon Parenteral Drugs Basic Information
Table 75. Patheon Parenteral Drugs Product Overview
Table 76. Patheon Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Patheon Business Overview
Table 78. Patheon Recent Developments
Table 79. BAG Healthcare Parenteral Drugs Basic Information
Table 80. BAG Healthcare Parenteral Drugs Product Overview
Table 81. BAG Healthcare Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. BAG Healthcare Business Overview
Table 83. BAG Healthcare Recent Developments
Table 84. Beximco Pharma Parenteral Drugs Basic Information
Table 85. Beximco Pharma Parenteral Drugs Product Overview
Table 86. Beximco Pharma Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Beximco Pharma Business Overview
Table 88. Beximco Pharma Recent Developments
Table 89. Baxter Healthcare Corporation Parenteral Drugs Basic Information
Table 90. Baxter Healthcare Corporation Parenteral Drugs Product Overview
Table 91. Baxter Healthcare Corporation Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Baxter Healthcare Corporation Business Overview
Table 93. Baxter Healthcare Corporation Recent Developments
Table 94. B. Braun Parenteral Drugs Basic Information
Table 95. B. Braun Parenteral Drugs Product Overview
Table 96. B. Braun Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. B. Braun Business Overview
Table 98. B. Braun Recent Developments
Table 99. Fresenius Parenteral Drugs Basic Information
Table 100. Fresenius Parenteral Drugs Product Overview
Table 101. Fresenius Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Fresenius Business Overview
Table 103. Fresenius Recent Developments
Table 104. Albert David Parenteral Drugs Basic Information
Table 105. Albert David Parenteral Drugs Product Overview
Table 106. Albert David Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Albert David Business Overview
Table 108. Albert David Recent Developments
Table 109. BML Parenteral Drugs Parenteral Drugs Basic Information
Table 110. BML Parenteral Drugs Parenteral Drugs Product Overview
Table 111. BML Parenteral Drugs Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. BML Parenteral Drugs Business Overview
Table 113. BML Parenteral Drugs Recent Developments
Table 114. Pfizer (Hospira) Parenteral Drugs Basic Information
Table 115. Pfizer (Hospira) Parenteral Drugs Product Overview
Table 116. Pfizer (Hospira) Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Pfizer (Hospira) Business Overview
Table 118. Pfizer (Hospira) Recent Developments
Table 119. Pisa Parenteral Drugs Basic Information
Table 120. Pisa Parenteral Drugs Product Overview
Table 121. Pisa Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Pisa Business Overview
Table 123. Pisa Recent Developments
Table 124. Ozon Pharmaceuticals Ltd Parenteral Drugs Basic Information
Table 125. Ozon Pharmaceuticals Ltd Parenteral Drugs Product Overview
Table 126. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Ozon Pharmaceuticals Ltd Business Overview
Table 128. Ozon Pharmaceuticals Ltd Recent Developments
Table 129. Aspen Holdings Parenteral Drugs Basic Information
Table 130. Aspen Holdings Parenteral Drugs Product Overview
Table 131. Aspen Holdings Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Aspen Holdings Business Overview
Table 133. Aspen Holdings Recent Developments
Table 134. PSI Ltd Parenteral Drugs Basic Information
Table 135. PSI Ltd Parenteral Drugs Product Overview
Table 136. PSI Ltd Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. PSI Ltd Business Overview
Table 138. PSI Ltd Recent Developments
Table 139. Wintac Limited Parenteral Drugs Basic Information
Table 140. Wintac Limited Parenteral Drugs Product Overview
Table 141. Wintac Limited Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Wintac Limited Business Overview
Table 143. Wintac Limited Recent Developments
Table 144. AXA Parenterals Ltd Parenteral Drugs Basic Information
Table 145. AXA Parenterals Ltd Parenteral Drugs Product Overview
Table 146. AXA Parenterals Ltd Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. AXA Parenterals Ltd Business Overview
Table 148. AXA Parenterals Ltd Recent Developments
Table 149. Acebright Parenteral Drugs Basic Information
Table 150. Acebright Parenteral Drugs Product Overview
Table 151. Acebright Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Acebright Business Overview
Table 153. Acebright Recent Developments
Table 154. Southwest Pharmaceutical Parenteral Drugs Basic Information
Table 155. Southwest Pharmaceutical Parenteral Drugs Product Overview
Table 156. Southwest Pharmaceutical Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. Southwest Pharmaceutical Business Overview
Table 158. Southwest Pharmaceutical Recent Developments
Table 159. Abbott Parenteral Drugs Basic Information
Table 160. Abbott Parenteral Drugs Product Overview
Table 161. Abbott Parenteral Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 162. Abbott Business Overview
Table 163. Abbott Recent Developments
Table 164. Global Parenteral Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 165. Global Parenteral Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 166. North America Parenteral Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 167. North America Parenteral Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 168. Europe Parenteral Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 169. Europe Parenteral Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 170. Asia Pacific Parenteral Drugs Sales Forecast by Region (2025-2032) & (K MT)
Table 171. Asia Pacific Parenteral Drugs Market Size Forecast by Region (2025-2032) & (M USD)
Table 172. South America Parenteral Drugs Sales Forecast by Country (2025-2032) & (K MT)
Table 173. South America Parenteral Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 174. Middle East and Africa Parenteral Drugs Consumption Forecast by Country (2025-2032) & (Units)
Table 175. Middle East and Africa Parenteral Drugs Market Size Forecast by Country (2025-2032) & (M USD)
Table 176. Global Parenteral Drugs Sales Forecast by Type (2025-2032) & (K MT)
Table 177. Global Parenteral Drugs Market Size Forecast by Type (2025-2032) & (M USD)
Table 178. Global Parenteral Drugs Price Forecast by Type (2025-2032) & (USD/MT)
Table 179. Global Parenteral Drugs Sales (K MT) Forecast by Application (2025-2032)
Table 180. Global Parenteral Drugs Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Parenteral Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Parenteral Drugs Market Size (M USD), 2019-2032
Figure 5. Global Parenteral Drugs Market Size (M USD) (2019-2032)
Figure 6. Global Parenteral Drugs Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Parenteral Drugs Market Size by Country (M USD)
Figure 11. Parenteral Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Parenteral Drugs Revenue Share by Manufacturers in 2023
Figure 13. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Parenteral Drugs Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Parenteral Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Parenteral Drugs Market Share by Type
Figure 18. Sales Market Share of Parenteral Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Parenteral Drugs by Type in 2023
Figure 20. Market Size Share of Parenteral Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Parenteral Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Parenteral Drugs Market Share by Application
Figure 24. Global Parenteral Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Parenteral Drugs Sales Market Share by Application in 2023
Figure 26. Global Parenteral Drugs Market Share by Application (2019-2024)
Figure 27. Global Parenteral Drugs Market Share by Application in 2023
Figure 28. Global Parenteral Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Parenteral Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Parenteral Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Parenteral Drugs Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Parenteral Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Parenteral Drugs Sales Market Share by Country in 2023
Figure 37. Germany Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Parenteral Drugs Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Parenteral Drugs Sales Market Share by Region in 2023
Figure 44. China Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Parenteral Drugs Sales and Growth Rate (K MT)
Figure 50. South America Parenteral Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Parenteral Drugs Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Parenteral Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Parenteral Drugs Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Parenteral Drugs Production Market Share by Region (2019-2024)
Figure 62. North America Parenteral Drugs Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Parenteral Drugs Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Parenteral Drugs Production (K MT) Growth Rate (2019-2024)
Figure 65. China Parenteral Drugs Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Parenteral Drugs Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Parenteral Drugs Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Parenteral Drugs Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Parenteral Drugs Market Share Forecast by Type (2025-2032)
Figure 70. Global Parenteral Drugs Sales Forecast by Application (2025-2032)
Figure 71. Global Parenteral Drugs Market Share Forecast by Application (2025-2032)
